5 December 2018 in Akusherstvo i ginekologiia
2R2 Central Research Institute of Epidemiology of Rospotrebnadzor
2 Central Research Institute of Epidemiology of Rospotrebnadzor
+3
3 January 2017 in Journal of Endometriosis and Pelvic Pain Disorders
Background: The aim of the study was to evaluate the efficacy and safety of postoperative dienogest treatment in endometriosis patients. Materials and methods: A total of 53 patients suffering from endometriosis were enrolled. All participants underwent laparoscopic operative treatment. Afterwards, all patients were divided into 2 groups: Group 1 (control group) and Group 2 (receiving dienogest 2 mg/day after surgery). Comparative analysis was performed evaluating patients’ condition and complaints in the postoperative period, the disease dynamics at 3 and 6 months after the surgery, pain assessment (visual analogue scale) and severity of metrorrhagia in both groups. Results: Postoperative dienogest treatment reduces the severity of symptoms and improves treatment outcomes in endometriosis patients, leading to the improvement of the quality of life in these patients. Conclusions: Dienogest (2 mg/day) is a highly effective drug for postoperative treatment of patients with endometriosis. Dienogest (2 mg/day) significantly decreases the severity of pelvic pain and metrorrhagia after surgery. The medication is safe and side effects are rare.
1 January 2020 in Russian Journal of Woman and Child Health
M2Moscow City Clinical Hospital No. 24
Moscow City Clinical Hospital No. 24
+1
Антропометрический скрининг массы и длины тела новорожденного. Многоплодная беременности четко не. Двойня.
1 January 2016 in Voprosy Ginekologii, Akušerstva i Perinatologii
6 February 2020 in Clinical Case Reports
Extraintestinal symptoms of Crohn's disease may occur in the eye, the urinary system, on the skin, or subcutaneous fat. We report the case of a 7‐year diagnostic search of isolated vulvar Crohn's disease in a 47‐year‐old woman. The disease is characterized by gradual formation of pronounced bilateral asymmetric labial hypertrophy.
30 May 2022 in Akusherstvo i ginekologiia
KKKazantseva V.D. Kazantseva
Kazantseva V.D. Kazantseva
DYDobrokhotova Yu.E. Dobrokhotova Yu
Dobrokhotova Yu.E. Dobrokhotova Yu